Affymax To Pay J&J Unit $13M In Anemia Drug IP Dispute

Law360, New York (November 9, 2011, 5:23 PM EST) -- Affymax Inc. on Wednesday agreed to pay $13 million to settle a suit it had brought in Illinois federal court against a Johnson & Johnson unit over the ownership of several patents covering a drug to treat anemia in chronic kidney disease patients.

Affymax launched the suit in 2004, asking the court to rule on which company was entitled to ownership of the patents that had emerged from a joint research collaborations in the early 1990s. Janssen struck back with counterclaims arguing that the patents at...
To view the full article, register now.